Meckel's diverticulum is a tubular outpouching from the wall of small intestine. It is present at birth ('congenital'), and is the most common congenital anomaly of the digestive system. Meckel's diverticulum is present in ~2% of population, and in that complications occur in 4 - 6% of cases. So, in most cases Meckel's diverticulum is either not discovered, or even if discovered, nothing needs to be done in response.
Possible complications of Meckel's diverticulum include bleeding, obstruction, inflammation and perforation.
The mucosa (inner most lining) of Meckel's diverticulum can function like that of other organs ('heterotopic mucosa'). Most commonly the mucosa cells behave similar to the stomach (50% cases) and pancreas (5% cases). Meckel's diverticula with stomach or pancreas-like function are more likely to develop complications because of acid content (produced by stomach) and erosive proteins (called 'enzymes' produced by the pancreas).
The radiopharmaceutical (RP), i.e., the radioactive drug used for scanning procedure (i.e., 'pertechnetate') is taken up more avidly by the thyroid cells and stomach mucosa cells compared to rest of the body. As most of the the Meckel's diverticula cases express cells with stomach-like functions, they also selectively take up pertechnetate, which is what allows for its detections.
Although complications related to Meckel's diverticulum can manifest in adults, patients are most commonly young children of < 2 years' age.
There are no remarkable expected risks or side effects.
For additional information, please visit the following links.